Last reviewed · How we verify

NCT04738721

Physical Activity and Physical Fitness Parameters in COVID-19 Lockdown

Completed Last updated 5 May 2021
What this trial tests

trial testing Evaluation in Assessment, Self in 79 participants. Completed in 4 May 2021.

Timeline
5 February 2021
Primary endpoint
4 April 2021
4 May 2021

Quick facts

Lead sponsorMedipol University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment79
Start date5 February 2021
Primary completion4 April 2021
Estimated completion4 May 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Medipol University

Who can join

Adults 18 to 22, any sex, with Assessment, Self. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study; it was aimed to compare the physical activity levels of students who continued their university education face-to-face before the COVID-19 lockdown, and the values of physical activity levels related to health, physical activity levels and health-related physical fitness parameters in the post-lockdown period.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Evaluation

Trials testing the same drug.

Other recruiting trials for Assessment, Self

Currently open trials in the same condition.

Other Medipol University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04738721.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing